T. Rydén
发表
P. Bernhardt,
M. van Essen,
Jehangir Khan,
2021,
Radiation protection dosimetry.
M. Sigvardsson,
S. Jacobsen,
Christina T Jensen,
2008,
Blood.
P. Bernhardt,
M. van Essen,
T. Rydén,
2019,
The Journal of Nuclear Medicine.
P. Bernhardt,
T. Rydén,
J. Svensson,
2017,
Cancer biotherapy & radiopharmaceuticals.
U. Köster,
P. Bernhardt,
C. Müller,
2020,
EJNMMI Physics.
receptors in early T-cell development Permissive roles of hematopoietin and cytokine tyrosine kinase
Christina T Jensen,
E. Sitnicka,
T. Rydén,
2013
.
R. Baum,
R. Schibli,
C. Schuchardt,
2021,
The Journal of Nuclear Medicine.
Optimizing the Schedule of PARP Inhibitors in Combination with 177Lu-DOTATATE: A Dosimetry Rationale
P. Bernhardt,
J. Beauregard,
T. Rydén,
2021,
Biomedicines.
Mattias Höglund,
Srinivas Veerla,
Attila Frigyesi,
2010,
Cancer research.
P. Woll,
P. Vyas,
K. Anderson,
2010,
The New England journal of medicine.
Mattias Höglund,
Martin Lauss,
Attila Frigyesi,
2010,
BMC Cancer.
Per Thunberg,
Tobias Rydén,
Christoffer Andersén,
2020,
Medical physics.
P. Bernhardt,
T. Rydén,
J. Svensson,
2016,
EJNMMI Physics.
M Båth,
P. Bernhardt,
M. Båth,
2018,
EJNMMI Physics.
Tobias Rydén,
Ida Marin,
Peter Bernhardt,
2020,
The Journal of Nuclear Medicine.
Tobias Rydén,
T. Rydén,
2016
.
E. Wikberg,
P. Bernhardt,
M. van Essen,
2021,
Radiation protection dosimetry.
E. Wikberg,
P. Bernhardt,
M. van Essen,
2023,
EJNMMI Physics.
P. Bernhardt,
M. van Essen,
T. Rydén,
2021,
Radiation protection dosimetry.
E. Wikberg,
M. Essen,
T. Rydén,
2024,
EJNMMI physics.
M. van Essen,
T. Rydén,
J. Svensson,
2024,
EJNMMI physics.
R. Schibli,
C. Schuchardt,
P. Grundler,
2022
.